tetano
Editor, Senior Moderator
Cureus
. 2022 May 23;14(5):e25264.
doi: 10.7759/cureus.25264. eCollection 2022 May.
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
Eiman Elhouderi[SUP] 1 [/SUP], Eman Elsawalhy[SUP] 1 [/SUP], Mohamed Kabbani[SUP] 1 [/SUP]
Affiliations
Abstract
Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.
Keywords: covid-19 infection; covid-19 vaccine; m-rna vaccine; myocarditis; pericarditis.
. 2022 May 23;14(5):e25264.
doi: 10.7759/cureus.25264. eCollection 2022 May.
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19
Eiman Elhouderi[SUP] 1 [/SUP], Eman Elsawalhy[SUP] 1 [/SUP], Mohamed Kabbani[SUP] 1 [/SUP]
Affiliations
- PMID: 35755512
- PMCID: PMC9224764
- DOI: 10.7759/cureus.25264
Abstract
Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.
Keywords: covid-19 infection; covid-19 vaccine; m-rna vaccine; myocarditis; pericarditis.
